|
| 37748124 | Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial. | J Clin Oncol | 2024 |
| 35307323 | Local Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion. | Eur Urol Oncol | 2023 |
| 37478850 | Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer. | Cancer Cell | 2023 |
| 37949730 | Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer. | Eur Urol Oncol | 2023 |
| 37815783 | Anti-ceramide Single-Chain Variable Fragment Mitigates Gastrointestinal-Acute Radiation Syndrome and Improves Marrow Reconstitution, Rendering Near-Normal 90-Day Autopsies. | Int J Radiat Oncol Biol Phys | 2023 |
| 37305071 | Accelerated Partial Breast Irradiation: Association of Dosimetric Parameters With Patient-Reported Outcomes. | Adv Radiat Oncol | 2023 |
| 37267948 | Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. | Cell | 2023 |
| 36749798 | Macrophages promote anti-androgen resistance in prostate cancer bone disease. | J Exp Med | 2023 |
| 36586493 | A Multicenter Prospective Trial of Electronic Skin Surface Brachytherapy for Keratinocyte Carcinoma: Early Cosmesis, Quality of Life, and Adverse Events. | Int J Radiat Oncol Biol Phys | 2023 |
| 36549340 | SBRT focal dose intensification using an MR-Linac adaptive planning for intermediate-risk prostate cancer: An analysis of the dosimetric impact of intra-fractional organ changes. | Radiother Oncol | 2023 |
| 36918130 | Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer. | Int J Radiat Oncol Biol Phys | 2023 |
| 36765795 | Longitudinal Evaluation of Brain Plasticity in Low-Grade Gliomas: fMRI and Graph-Theory Provide Insights on Language Reorganization. | Cancers (Basel) | 2023 |
| 36155213 | Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy. | Int J Radiat Oncol Biol Phys | 2023 |
| 34114372 | A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer. | Cancer Rep (Hoboken) | 2022 |
| 35802849 | Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis. | J Clin Oncol | 2022 |
| 35544650 | Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis. | JCO Oncol Pract | 2022 |
| 35725549 | Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost. | Brachytherapy | 2022 |
| 35483522 | Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis. | Kidney Int | 2022 |
| 36037065 | Acid Sphingomyelinase-Ceramide Induced Vascular Injury Determines Colorectal Cancer Stem Cell Fate. | Cell Physiol Biochem | 2022 |
| 36185296 | Radiation therapy for <i>de novo</i> anorectal cancer in patients with a history of prostate radiation therapy. | Front Oncol | 2022 |
| 36115426 | Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation. | Urology | 2022 |
| 35260534 | Disruption of the crypt niche promotes outgrowth of mutated colorectal tumor stem cells. | JCI Insight | 2022 |
| 34388295 | Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity. | BJU Int | 2022 |
| 32726432 | Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. | J Natl Cancer Inst | 2021 |
| 33787863 | Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients. | Blood Adv | 2021 |
| 33587971 | Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy. | Radiother Oncol | 2021 |
| 33704353 | Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer. | JAMA Oncol | 2021 |
| 33586179 | Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center. | Int J Cancer | 2021 |
| 33724956 | Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair. | JCI Insight | 2021 |
| 35071829 | Factors Associated With Premature Ovarian Insufficiency in Young Women With Locally Advanced Rectal Cancer Treated With Pelvic Radiation Therapy. | Adv Radiat Oncol | 2021 |
| 34529789 | Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients? | Blood Adv | 2021 |
| 34585024 | Should Postoperative Radiation for Long Bone Metastases Cover Part or All of the Orthopedic Hardware? Results of a Large Retrospective Analysis. | Adv Radiat Oncol | 2021 |
| 34417459 | Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers. | Nat Commun | 2021 |
| 34532124 | Ablative radiation therapy for hepatocellular carcinoma is associated with reduced treatment- and tumor-related liver failure and improved survival. | J Gastrointest Oncol | 2021 |
| 34250389 | Tolerability of Breast Radiotherapy Among Carriers of <i>ATM</i> Germline Variants. | JCO Precis Oncol | 2021 |
| 34293201 | Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial. | Cancer | 2021 |
| 34140615 | Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer. | Sci Rep | 2021 |
| 33371964 | 10-Year Breast Cancer Outcomes in Women ⿤35 Years of Age. | Int J Radiat Oncol Biol Phys | 2021 |
| 33429428 | Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. | J Natl Cancer Inst | 2021 |
| 33188862 | Trends in Radiation Therapy for Bone Metastases, 2015 to 2017: Choosing Wisely in the Era of Complex Radiation. | Int J Radiat Oncol Biol Phys | 2021 |
| 33422612 | Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer. | Int J Radiat Oncol Biol Phys | 2021 |
| 33245144 | Oral self-management of palbociclib (Ibrance®) using mobile technology protocol. | J Adv Nurs | 2021 |
| 33203894 | Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis. | Lab Invest | 2021 |
| 32822275 | Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. | J Clin Oncol | 2021 |
| 32592583 | Clinical trial of proton craniospinal irradiation for leptomeningeal metastases. | Neuro Oncol | 2021 |
| 31608751 | Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy. | Acta Oncol | 2020 |
| 33665486 | Urinary Outcomes for Men With High Baseline International Prostate Symptom Scores Treated With Prostate SBRT. | Adv Radiat Oncol | 2020 |
| 31934827 | Decreased Hand Motor Resting-State Functional Connectivity in Patients with Glioma: Analysis of Factors including Neurovascular Uncoupling. | Radiology | 2020 |
| 31873875 | DCE-MRI perfusion predicts pseudoprogression in metastatic melanoma treated with immunotherapy. | J Neurooncol | 2020 |
| 31668713 | Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer. | Eur Urol Oncol | 2020 |